Visual Disorders in Parkinson's Disease

Completed

• Conditions: Parkinson's disease; Parkinsons; 10028037

• Registration Number: NL-OMON42851
• Lead Sponsor: Radboud Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 2019-12-09
• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Patients that were diagnosed with PD by a neurologist at age >30 years at time of diagnosis will be included.

Exclusion Criteria

- Previous eye surgery other than phacoemulsification for cataract
- blindness in 1 eye.
- Medication that influences normal visual function other than PD medication13 (parasympathicolytic function, phenothiazines, sulphonamides, tetracyclines, isotretinoïn).
- Systemic diseases associated with eye problems14 (sjögren*s disease, marfan, myotonic dystrophy, M. Bechterew, M. Wegener).
- History of lesions near the optic chiasm or occipital cortex (e.g. tumor, infarct, bleed); migraine.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Endpoints include both ophthalmological outcomes and clinical outcomes.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n.a.</p><br>